Dr. Jason L. Chang, MD

Dr. Chang practices at The Hospital of Central Connecticut in New Britain, Connecticut, part of Hartford HealthCare.

Dr. Chang's NPI, 1174739072, was assigned on May 15, 2007. Dr. Chang graduated from New York University School of Medicine in 2004. Dr. Chang holds Connecticut license 049717.

Dr. Chang's primary practice is The Hospital of Central Connecticut, at 100 Grand Street, New Britain, CT 06050 in Hartford County. The practice phone is (860) 224-5011.

Dr. Chang's primary practice is The Hospital of Central Connecticut in New Britain, Connecticut, part of Hartford HealthCare. Dr. Chang is also affiliated with Hartford Hospital. The medical group on file is The Hospital of Central Connecticut. Dmand AI also links Dr. Chang to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chang is board certified in hematology by the American Board of Internal Medicine. Dr. Chang is licensed in Connecticut.

CMS data shows 863 Medicare services from Dr. Chang across 7 procedure codes in 2024, for 186 Medicare patients. Medicare paid $62,591 for them.

CMS counts 186 Medicare patients who saw Dr. Chang in 2024. The largest group is 75 to 84, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 64, with 67% women.

In 2024, Dr. Chang wrote 1,228 Medicare Part D claims for 161 patients. 76% of them were for generic drugs. CMS names the drug for 1,023 of them, across 28 drugs with 11 or more claims each, at $1,760,047 in total drug cost. In 2023, CMS named 1,065 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chang for performance year 2024, reported as part of a group. Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth.

CMS Open Payments shows 11 general payments to Dr. Chang from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. Abbott Laboratories paid the most, $171.

Dr. Chang graduated from New York University School of Medicine in 2004.